Fusions in neuregulin 1 (NRG1) and neuregulin 2 (NRG2) genes are molecular features of non-small cell lung cancer. These rearrangements enhance ectopic expression of the NRG/ErbB receptor‐ligand and induce the triggering of downstream pathways.
[Expert Opinion On Therapeutic Targets]
6445212
SPXSDFJC
items
1
apa
0
default
asc
1
168392
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
